Latest News for: cdk7

Edit

Qurient Announces Collaboration Agreement with MSD to Evaluate Selective CDK7 Inhibitor Q901 in Combination With ...

The Galveston Daily News 15 Sep 2022
Q901 is a highly selective cyclin dependent kinase 7 (CDK7) inhibitor that only inhibits CDK7 in the human kinome. CDK7 is a master regulator of cell cycle checkpoints and an essential component of transcription machinery.
  • 1

Most Viewed

×